Recombinant Human ANTXR1 Protein, C-His tag_天津卡梅德科技发展有限公司

Recombinant Human ANTXR1 Protein, C-His tag

产品编号

KMH675

别名

抗毒素受体1, ATR, GAPO, TEM8, ANTXR cell adhesion molecule 1

规格

20ug
50ug
100ug
200ug
1mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Catalog Number	KMH675
Alias	抗毒素受体1, ATR, GAPO, TEM8, ANTXR cell adhesion molecule 1
Size	20ug, 50ug, 100ug, 200ug, 1mg
Product Description	KMH675 Recombinant Human ANTXR1 Protein, C-His tag contains the human ANTXR1(33-321 aa) was expressed in Mammalian cells.
Molecular Name	ANTXR1
Product Introduction	ANTXR1 (KMH675) 在细胞迁移、发育和免疫反应中起到重要作用。
Molecular Weight	38-46 kDa
Expression System	HEK293F Cells
Species	Human
Concentration	联系销售经理获得最新批次的浓度
Purity	≥95%
SDS-PAGE
Purification	Affinity Purification
Uniprot ID	Q9H6X2
Storage Condition	Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles.
Formulation	PBS
Shipping Condition	This product is shipped on ice packs or dry ice.
Background	Anthrax Toxin Receptor 1 (ANTXR1) is a single-pass type I membrane protein that belongs to the ATR family. ANTXR1 contains one VWFA domain and binds PA through the VWA domain. ANTXR1 is highly expressed in tumor endothelial cells. ANTXR1 plays a role in cell attachment and migration. ANTXR1 interacts with extracellular matrix proteins and the actin cytoskeleton, it mediates adhesion of cells to type 1 collagen and gelatin, reorganization of the actin cytoskeleton and promotes cell spreading. It is also involved in the angiogenic response of cultured umbilical vein endothelial cells, up-regulated in cultured angiogenic umbilical vein endothelial cells. Defects in ANTXR1 are associated with susceptibility to hemangioma capillary infantile (HCI).
Endotoxin	< 0.1 EU per ug
Protein Family	Other protein
Biological Activity	Measured by its binding ability in a functional ELISA. When Anthrax Protective Antigen is coated at 1.5 μg/mL (100 μL/well), the concentration of Recombinant Human TEM8/ANTXR1 that produces 50% optimal binding response is 0.6-3.6 μg/mL.
Product Declaration	该产品仅供科研使用，不可直接用于人体或注射。